502 results on '"Klink, Barbara"'
Search Results
2. Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
3. The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions
4. Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
5. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases
6. Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis
7. Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe
8. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go
9. Genetic counselling legislation and practice in cancer in EU Member States
10. Genetic counselling legislation and practice in cancer in EU Member States.
11. Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile
12. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
13. Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
14. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion
15. The landscape of chromothripsis across adult cancer types
16. Digital PCR Cluster Predictor: a universal R-package and Shiny app for the automated analysis of multiplex digital PCR data
17. Supplementary Patient Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
18. Data from Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
19. Supplementary Table S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
20. Supplementary Tables S1-S7 from Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
21. Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
22. Supplementary Figure S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
23. Supplementary Figures S1-S10 from Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
24. Supplementary Methods from Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
25. Supplementary Table S2 from An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells
26. Data from An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells
27. Supplementary Figures S1-S10 from An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells
28. Supplementary Data from The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity
29. Supplementary Methods and Reference from An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells
30. Glioblastoma-instructed microglia transit to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts
31. Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs
32. Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples
33. Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
34. Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia
35. Sensitization of Patient-Derived Colorectal Cancer Organoids to Photon and Proton Radiation by Targeting DNA Damage Response Mechanisms
36. Proteogenomic analysis reveals RNA as an important source for tumor-agnostic neoantigen identification correlating with T-cell infiltration
37. CASP9 germline mutation in a family with multiple brain tumors
38. Author Correction: Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia
39. Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion
40. Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups
41. Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH
42. Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
43. Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
44. The histone demethylase UTX regulates stem cell migration and hematopoiesis
45. Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
46. Precision oncology based on omics data: The NCT Heidelberg experience
47. HBOC multi-gene panel testing: comparison of two sequencing centers
48. Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH Mutant and Wild-Type Glioma Cell Model
49. Understanding the new BRD4‐related syndrome: Clinical and genomic delineation with an international cohort study
50. Deciphering Human Glioblastoma Invasion Using a Developmental Mature Rat Brain Organoid Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.